Literature DB >> 28543878

MITAP-compliant characterization of human regulatory macrophages.

James A Hutchinson1, Nobert Ahrens2, Edward K Geissler1.   

Abstract

This article provides a transparent description of Mreg_UKR cell products, including manufacture and quality-control processes, using the structure and vocabulary of the 'Minimum Information about Tolerogenic Antigen-presenting Cells' reporting guidelines. This information is intended as a resource for those in the field, as well as a stimulus to develop a new wave of immunoregulatory and tissue-reparative monocyte-derived cell therapies.
© 2017 Steunstichting ESOT.

Entities:  

Keywords:  Mreg; cell-based therapy; minimum information about tolerogenic antigen-presenting cells; monocyte; regulatory macrophage; solid organ transplantation; suppressor macrophage; tolerogenic antigen presenting cell (APC)

Mesh：

Year:  2017        PMID： 28543878     DOI： 10.1111/tri.12988

Source DB:  PubMed          Journal:  Transpl Int        ISSN： 0934-0874            Impact factor:   3.782


  7 in total

Review 1.  Myeloid and Mesenchymal Stem Cell Therapies for Solid Organ Transplant Tolerance.

Authors:  Jennifer Li; Angus W Thomson; Natasha M Rogers
Journal:  Transplantation       Date:  2021-12-01       Impact factor: 5.385

2.  Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials.

Authors:  Birgit Sawitzki; Paul N Harden; Petra Reinke; Aurélie Moreau; James A Hutchinson; David S Game; Qizhi Tang; Eva C Guinan; Manuela Battaglia; William J Burlingham; Ian S D Roberts; Mathias Streitz; Régis Josien; Carsten A Böger; Cristiano Scottà; James F Markmann; Joanna L Hester; Karsten Juerchott; Cecile Braudeau; Ben James; Laura Contreras-Ruiz; Jeroen B van der Net; Tobias Bergler; Rossana Caldara; William Petchey; Matthias Edinger; Nathalie Dupas; Michael Kapinsky; Ingrid Mutzbauer; Natalie M Otto; Robert Öllinger; Maria P Hernandez-Fuentes; Fadi Issa; Norbert Ahrens; Christoph Meyenberg; Sandra Karitzky; Ulrich Kunzendorf; Stuart J Knechtle; Josep Grinyó; Peter J Morris; Leslie Brent; Andrew Bushell; Laurence A Turka; Jeffrey A Bluestone; Robert I Lechler; Hans J Schlitt; Maria C Cuturi; Stephan Schlickeiser; Peter J Friend; Tewfik Miloud; Alexander Scheffold; Antonio Secchi; Kerry Crisalli; Sang-Mo Kang; Rachel Hilton; Bernhard Banas; Gilles Blancho; Hans-Dieter Volk; Giovanna Lombardi; Kathryn J Wood; Edward K Geissler
Journal:  Lancet       Date:  2020-05-23       Impact factor: 202.731

3.  Transcriptomics uncovers substantial variability associated with alterations in manufacturing processes of macrophage cell therapy products.

Authors:  Olga L Gurvich; Katja A Puttonen; Aubrey Bailey; Anssi Kailaanmäki; Vita Skirdenko; Minna Sivonen; Sanna Pietikäinen; Nigel R Parker; Seppo Ylä-Herttuala; Tuija Kekarainen
Journal:  Sci Rep       Date:  2020-08-20       Impact factor: 4.379

Review 4.  Macrophages in Organ Transplantation.

Authors:  Farideh Ordikhani; Venu Pothula; Rodrigo Sanchez-Tarjuelo; Stefan Jordan; Jordi Ochando
Journal:  Front Immunol       Date:  2020-11-30       Impact factor: 7.561

Review 5.  Detection and Monitoring of Regulatory Immune Cells Following Their Adoptive Transfer in Organ Transplantation.

Authors:  Lillian M Tran; Angus W Thomson
Journal:  Front Immunol       Date:  2020-12-14       Impact factor: 7.561

6.  TIGIT+ iTregs elicited by human regulatory macrophages control T cell immunity.

Authors:  Paloma Riquelme; Jan Haarer; Anja Kammler; Lisa Walter; Stefan Tomiuk; Norbert Ahrens; Anja K Wege; Ivan Goecze; Daniel Zecher; Bernhard Banas; Rainer Spang; Fred Fändrich; Manfred B Lutz; Birgit Sawitzki; Hans J Schlitt; Jordi Ochando; Edward K Geissler; James A Hutchinson
Journal:  Nat Commun       Date:  2018-07-20       Impact factor: 14.919

Review 7.  Searching for the Transcriptomic Signature of Immune Tolerance Induction-Biomarkers of Safety and Functionality for Tolerogenic Dendritic Cells and Regulatory Macrophages.

Authors:  Juan Navarro-Barriuso; María José Mansilla; Eva M Martínez-Cáceres
Journal:  Front Immunol       Date:  2018-09-19       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.